Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States
2019 ◽
Vol 23
(1)
◽
pp. 37-47
◽
Keyword(s):
2012 ◽
Vol 15
(4)
◽
pp. 712-723
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 21
(5)
◽
pp. 525-536
◽
2017 ◽
Vol 25
(6)
◽
pp. 1845-1851
◽
Keyword(s):
2013 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2021 ◽
pp. 1-13
Keyword(s):